2610
Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses resulted in mild, transient neurological symptoms (paresthesias) in only one of 30 patients so treated.
 one of 30 patients: Subject; one of 30: Subject.Population; neurological symptoms: Effect; Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses: Treatment; intrathecal: Treatment.Route; Ara-C: Treatment.Drug; longer intervals within 3-5 days between consecutive doses: Treatment.Freq
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 one of 30 patients: Subject; one of 30: Subject.Population; neurological symptoms: Effect; Administration of intrathecal Ara-C in the same dose over longer intervals within 3-5 days between consecutive doses: Treatment; intrathecal: Treatment.Route; Ara-C: Treatment.Drug; longer intervals within 3-5 days between consecutive doses: Treatment.Freq